Qian Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qian Yang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Yu Wang
School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
3 shared publications - Rui Shao
State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
2 shared publications - Xin Zhao
Ministry of Education Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae Tianjin University of Traditional Chinese Medicine Tianjin China
2 shared publications - Chenyao Huang
State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
1 shared publication - Lin Ma
State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
1 shared publication - Qianru Zhao
State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by MDPI AG in Fermentation
- Vol. 12 (1) , 32
Microbial Cell Factories for Phenylethanoid Glycosides: A Review on Engineering Strategies and Perspectives
Due to the neuroprotective and antioxidant properties, phenylethanoid glycosides (PhGs) are valuable plant-derived compounds. Traditional extraction methods are constrained by low yields and limited resources, prompting the integration of synthetic biology and enzyme engineering technologies for sustainable production. This review summarizes the advances in the microbial synthesis of PhGs, emphasizing the elucidation of biosynthetic pathways, enzyme engineering modifications of glycosyltransferases and acyltransferases, and strategies for optimizing microbial cell factories in Escherichia coli and Saccharomyces cerevisiae. Significant advancements encompass the efficient synthesis of verbascoside and echinacoside in S. cerevisiae, as well as the comprehensive elucidation of the echinacoside biosynthetic pathway in Cistanche spp., including the identification of key steps catalyzed by a rhamnosyltransferase, a CYP450 hydroxylase, and a terminal glucosyltransferase that enable pathway reconstruction in S. cerevisiae. We conduct a systematic analysis of methods to address the biosynthetic bottlenecks via protein engineering, including rational design and directed evolution, as well as the metabolic engineering strategies such as precursor enhancement and cofactor recycling. Additionally, we investigate the synthesis of non-natural PhG analogues and the prospective integration with AI-assisted design, emphasizing the significant potential of microbial systems in overcoming the supply challenges for medicine-food homologous ingredients.
- 6 January 2026
- Published by MDPI AG in Fermentation
- Vol. 12 (1) , 32
Open AccessMicrobial Cell Factories for Phenylethanoid Glycosides: A Review on Engineering Strategies and Perspectives
Due to the neuroprotective and antioxidant properties, phenylethanoid glycosides (PhGs) are valuable plant-derived compounds. Traditional extraction methods are constrained by low yields and limited resources, prompting the integration of synthetic biology and enzyme engineering technologies for sustainable production. This review summarizes the advances in the microbial synthesis of PhGs, emphasizing the elucidation of biosynthetic pathways, enzyme engineering modifications of glycosyltransferases and acyltransferases, and strategies for optimizing microbial cell factories in Escherichia coli and Saccharomyces cerevisiae. Significant advancements encompass the efficient synthesis of verbascoside and echinacoside in S. cerevisiae, as well as the comprehensive elucidation of the echinacoside biosynthetic pathway in Cistanche spp., including the identification of key steps catalyzed by a rhamnosyltransferase, a CYP450 hydroxylase, and a terminal glucosyltransferase that enable pathway reconstruction in S. cerevisiae. We conduct a systematic analysis of methods to address the biosynthetic bottlenecks via protein engineering, including rational design and directed evolution, as well as the metabolic engineering strategies such as precursor enhancement and cofactor recycling. Additionally, we investigate the synthesis of non-natural PhG analogues and the prospective integration with AI-assisted design, emphasizing the significant potential of microbial systems in overcoming the supply challenges for medicine-food homologous ingredients.
- 1 January 2026
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 54 (03) , 795-825
Medicinal and Edible Plants for the Management of Inflammatory Bowel Disease: Synergistic Modulation of the Microbiota–Metabolite–Immune Axis
Inflammatory bowel disease (IBD) is a chronic condition driven by the intertwined interplay of gut dysbiosis, immune perturbation, and metabolic imbalance. Current single-target therapies often fail to durably restore homeostasis in this complex ecosystem, and have thereby increased interest in diet-based holistic interventions. Plants traditionally used as both food and medicine, such as Crataegus pinnatifida, Ganoderma lucidum, and Codonopsis pilosula, are natural products that possess both nutritional and therapeutic attributes. The use of such plants is commonly referred to as medicinal food homology (MFH) in East Asian literature. Their multi-component nature offers the potential to modulate intestinal homeostasis through multi-target synergy. This review systematically discusses how MFH regulates the “microbiota–metabolite–immune” axis via key bioactive constituents like polysaccharides, curcumin, and geniposide. Specifically, these constituents differentially influence short-chain fatty acid (SCFA) production, oxidative stress, and bile-acid signaling to thereby enable integrated regulation of the gut micro-ecosystem and host immune function. In parallel, we critically address the translational challenges of extrapolating animal-model findings to clinical applications, and propose a precision-intervention framework that integrates chemical standardization, multi-omics, artificial intelligence, and advanced ex vivo validation models to both overcome MFH’s intrinsic complexity and facilitate evidence-based, personalized IBD management.
- 1 January 2026
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 54 (03) , 795-825
Medicinal and Edible Plants for the Management of Inflammatory Bowel Disease: Synergistic Modulation of the Microbiota–Metabolite–Immune Axis
Inflammatory bowel disease (IBD) is a chronic condition driven by the intertwined interplay of gut dysbiosis, immune perturbation, and metabolic imbalance. Current single-target therapies often fail to durably restore homeostasis in this complex ecosystem, and have thereby increased interest in diet-based holistic interventions. Plants traditionally used as both food and medicine, such as Crataegus pinnatifida, Ganoderma lucidum, and Codonopsis pilosula, are natural products that possess both nutritional and therapeutic attributes. The use of such plants is commonly referred to as medicinal food homology (MFH) in East Asian literature. Their multi-component nature offers the potential to modulate intestinal homeostasis through multi-target synergy. This review systematically discusses how MFH regulates the “microbiota–metabolite–immune” axis via key bioactive constituents like polysaccharides, curcumin, and geniposide. Specifically, these constituents differentially influence short-chain fatty acid (SCFA) production, oxidative stress, and bile-acid signaling to thereby enable integrated regulation of the gut micro-ecosystem and host immune function. In parallel, we critically address the translational challenges of extrapolating animal-model findings to clinical applications, and propose a precision-intervention framework that integrates chemical standardization, multi-omics, artificial intelligence, and advanced ex vivo validation models to both overcome MFH’s intrinsic complexity and facilitate evidence-based, personalized IBD management.
- 1 January 2026
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 54 (02) , 627-659
Codonopsis pilosula (Dangshen) Alleviates Ulcerative Colitis Through Activation of the Aromatic Hydrocarbon Receptor Signaling Pathway by the Gut Bacterium Alistipes onderdonkii and Its Metabolite, 5-HIAA
Ulcerative colitis (UC) is a growing global health concern, but there remains a lack of natural food sources and multi-targeted drugs to effectively it. Codonopsis pilosula (dangshen, DS), a medicinal food used in traditional Chinese medicine, offers more comprehensive benefits than conventional drugs due to the numerous active compounds, such as lobetyolin, tangshenoside I, codonopsine, succinic acid, and raffinose, it contains. DS can be safely incorporated into diets to enhance UC treatment compliance and continuous management. This study explored the therapeutic effects and mechanisms of DS using microbial sequencing, metabolomics, and experimental validation. DS alleviated UC symptoms in mice to ultimately achieve reduced weight loss, colon shortening, disease activity, and histopathology scores. It lowered pro-inflammatory cytokine levels (IL-6, IL-1β, TNF-[ ], balanced Th17 and Treg cells, and enhanced the intestinal barrier integrity by upregulating tight junction proteins (ZO-1, occludin, E-cadherin). In addition, DS significantly reduced the abundance of pathogenic Escherichia–Shigella by modulating the composition of the intestinal flora and increasing the production of tryptophan metabolites (5-hydroxyindole-3-acetic acid (5-HIAA) and kynurenic acid (KYNA)) through probiotic bacteria, like Alistipes and Lactobacillus, which act as aromatic hydrocarbon receptor (AhR) ligands. We found that Alistipes onderdonkii cultured in vitro produced 5-HIAA, and that DS could further increase 5-HIAA levels. In addition, both 5-HIAA and DS activated AhR in turn. The diminished efficacy of DS in UC after colony clearance was accompanied by a decrease in the level of AhR, which suggests the importance of bacterial-derived metabolites as mediators of the efficacy of DS. The metabolomics results showed that DS mainly exerted its regulatory effects by modulating arachidonic acid metabolism and tryptophan metabolism. Based on our data, which elucidated the relationship between AhR and anti-inflammatory effects, we identified the AhR/NF-κBp65 signaling pathway as a potential pharmacological mechanism by which DS is associated with UC amelioration.
- 1 January 2026
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 54 (02) , 627-659
Codonopsis pilosula (Dangshen) Alleviates Ulcerative Colitis Through Activation of the Aromatic Hydrocarbon Receptor Signaling Pathway by the Gut Bacterium Alistipes onderdonkii and Its Metabolite, 5-HIAA
Ulcerative colitis (UC) is a growing global health concern, but there remains a lack of natural food sources and multi-targeted drugs to effectively it. Codonopsis pilosula (dangshen, DS), a medicinal food used in traditional Chinese medicine, offers more comprehensive benefits than conventional drugs due to the numerous active compounds, such as lobetyolin, tangshenoside I, codonopsine, succinic acid, and raffinose, it contains. DS can be safely incorporated into diets to enhance UC treatment compliance and continuous management. This study explored the therapeutic effects and mechanisms of DS using microbial sequencing, metabolomics, and experimental validation. DS alleviated UC symptoms in mice to ultimately achieve reduced weight loss, colon shortening, disease activity, and histopathology scores. It lowered pro-inflammatory cytokine levels (IL-6, IL-1β, TNF-[ ], balanced Th17 and Treg cells, and enhanced the intestinal barrier integrity by upregulating tight junction proteins (ZO-1, occludin, E-cadherin). In addition, DS significantly reduced the abundance of pathogenic Escherichia–Shigella by modulating the composition of the intestinal flora and increasing the production of tryptophan metabolites (5-hydroxyindole-3-acetic acid (5-HIAA) and kynurenic acid (KYNA)) through probiotic bacteria, like Alistipes and Lactobacillus, which act as aromatic hydrocarbon receptor (AhR) ligands. We found that Alistipes onderdonkii cultured in vitro produced 5-HIAA, and that DS could further increase 5-HIAA levels. In addition, both 5-HIAA and DS activated AhR in turn. The diminished efficacy of DS in UC after colony clearance was accompanied by a decrease in the level of AhR, which suggests the importance of bacterial-derived metabolites as mediators of the efficacy of DS. The metabolomics results showed that DS mainly exerted its regulatory effects by modulating arachidonic acid metabolism and tryptophan metabolism. Based on our data, which elucidated the relationship between AhR and anti-inflammatory effects, we identified the AhR/NF-κBp65 signaling pathway as a potential pharmacological mechanism by which DS is associated with UC amelioration.